Abrams Capital Management Q1 2026: Focus on Alphabet Inc. and Somnigroup Stock Adjustments
Abrams Capital Management's portfolio analysis for Q1 2026 shows notable reductions in Alphabet Inc. (GOOGL) and Somnigroup International Inc. (TPX), while Nuvation Bio Inc. (NUVB) saw a significant decrease in holdings.
David Abrams, managing Abrams Capital Management, has released portfolio data as of March 31, 2026. The disclosed holdings reveal a strategic adjustment period, with reductions observed across several key positions.
The investor's largest holding, Alphabet Inc. (GOOGL), representing approximately 11.57% of the portfolio, saw a reduction in shares during the quarter. The position decreased by 50,862 shares, a 2.65% reduction from the previous period.
Another significant position, Somnigroup International Inc. (TPX), allocated at 9.24% of the portfolio, also experienced a decline. The holding decreased by 5,360 shares, a minimal 0.09% reduction.
Meanwhile, the position in Nuvation Bio Inc. (NUVB) underwent a substantial reduction. The holding decreased by 2,541,009 shares, representing a drastic 66.67% reduction in shares during the quarter. Despite this significant share reduction, the stock's portfolio allocation percentage remained unchanged at 0.12%.
No new positions were disclosed in this filing, and no holdings appear to have been fully exited according to the provided data. For a complete view of David Abrams' investment activity, readers can visit the investor profile at Abrams Capital Management. Detailed analysis of Alphabet Inc. (GOOGL) can be found at GOO (Alphabet Inc.), Somnigroup International Inc. (TPX) at TPX (Somnigroup International Inc.), and Nuvation Bio Inc. (NUVB) at NUVB (Nuvation Bio Inc.).